## Distinguishing P. vivax from P. falciparum ### Key Biological & Epidemiological Differences **Key Point:** The presence of hypnozoites (dormant liver forms) in *P. vivax* is the single most important biological distinction, leading to relapse weeks to months after the primary attack — a feature absent in *P. falciparum*. **High-Yield:** *P. vivax* has a strong preference for **young RBCs (reticulocytes)**, limiting parasitemia to <1% typically, whereas *P. falciparum* infects RBCs of all ages, allowing parasitemia >20%. ### Comparison Table: P. vivax vs P. falciparum | Feature | P. vivax | P. falciparum | | --- | --- | --- | | **Hypnozoites** | Present → relapse | Absent | | **RBC preference** | Reticulocytes only | All ages | | **Max parasitemia** | <1% | >20% | | **Geographic range** | Temperate & subtropical | Tropical & subtropical | | **Cerebral malaria** | Rare | Common (10–15%) | | **Severe complications** | ARDS, acute kidney injury | Cerebral, renal, pulmonary | | **Relapse pattern** | Yes (6–12 months) | No | **Clinical Pearl:** *P. vivax* relapses occur because hypnozoites remain dormant in hepatocytes and can be reactivated months later, even after successful treatment of the erythrocytic stage. This is why primaquine (8-aminoquinoline) is mandatory for *P. vivax* to prevent relapse. **Mnemonic: VIVAX RELAPSE** — **V**ivax has **H**ypnozoites → **H**olds back in **H**epatocytes → **H**appens again (relapse). ### Why the Correct Answer Stands Option 2 (relapse + temperate climate) uniquely captures the defining epidemiological and parasitological feature of *P. vivax*: the ability to relapse due to hypnozoites, combined with its preference for cooler climates (India's Western Ghats, parts of Himalayas). This is the single best discriminator in clinical practice and public health surveillance. [cite:Park 26e Ch 3]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.